Last edition
News about "Chiba GMP facility"
AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance
AGC Biologics will provide process development and GMP manufacturing services for Teikoku Seiyaku’s rhMMP-7 therapy, supporting development of the novel biologic through its global microbial network in Germany and Japan.
Chiba GMP Facility | 26/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members